What’s Better: Ozempic or Mounjaro for Weight Loss?

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and tirzepatide represent two distinct approaches to GLP-1 therapy for weight management. While semaglutide activates only the GLP-1 receptor, tirzepatide acts on both GLP-1 and GIP receptors, creating a dual-hormone effect that may produce different weight-loss outcomes. Clinical trials show tirzepatide produces greater average weight reduction, but the right choice depends on your individual metabolic factors and health history.

How Semaglutide and Tirzepatide Work Differently

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone that slows stomach emptying and increases feelings of fullness. This single-pathway mechanism has proven effective for weight loss, with patients losing an average of 10-15% of body weight in clinical studies. The medication also improves blood sugar control and may reduce cardiovascular risk in people with obesity.

Tirzepatide activates both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual-action approach targets two separate metabolic pathways that regulate appetite and energy use. By engaging both receptors, tirzepatide produces a more comprehensive metabolic shift, leading to greater weight reduction in head-to-head trials—with patients averaging 20-22% body weight loss at the highest doses.

Clinical Trial Results: Weight Loss Comparison

The STEP trials demonstrated semaglutide's effectiveness, with participants losing 5-18% of baseline body weight depending on dose and individual response. These results established semaglutide as a gold-standard GLP-1 therapy and transformed weight-loss treatment. The consistency and tolerability of semaglutide made it widely adopted across clinical settings.

The SURMOUNT trials specifically compared tirzepatide to semaglutide and placebo. At equivalent timepoints, tirzepatide users lost significantly more weight than semaglutide users—up to 22% versus 16% at the highest doses studied. This 6-percentage-point difference represents a clinically meaningful advantage, though individual responses vary based on genetics, adherence, and lifestyle factors.

Side Effects and Tolerability Profile

Both medications cause similar gastrointestinal side effects, including nausea, vomiting, constipation, and diarrhea, particularly during dose escalation. Most patients experience mild symptoms that resolve within 2-4 weeks as the body adjusts. Serious adverse events are rare, and both medications are generally well-tolerated at maintenance doses.

Tirzepatide may produce more pronounced initial nausea due to its dual-receptor activation, meaning some patients require slower titration schedules. Semaglutide often allows faster dose escalation for patients with good tolerance. Neither medication is appropriate for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.

Choosing the Right Medication for Your Metabolism

Individual genetic factors influence how effectively each medication works. PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and identifies genetic variants in GLP1R, GIPR, FTO, and MC4R genes. These insights reveal whether your body is genetically predisposed to respond better to single-pathway or dual-pathway activation, informing the most personalized treatment choice.

PlexusDx compounded semaglutide starts at $149/month and tirzepatide injection starts at $249/month—priced flat regardless of your dose level. Your dose may need to go up. Your price won't. Both are available from licensed 503A compounding pharmacies across all 50 states without insurance, and both qualify for HSA/FSA accounts. Adding the Precision Peptide Genetic Test for $99 after your first month of treatment provides data-driven guidance on whether dual-action therapy aligns with your genetic predispositions.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will tirzepatide cause more side effects than semaglutide?

Tirzepatide activates two hormone pathways, which may produce slightly stronger initial nausea during the first weeks of treatment. However, both medications share the same side-effect profile overall. Most patients adapt within 2-4 weeks, and side effects decrease at stable maintenance doses. Your PlexusDx provider can adjust your titration schedule to improve tolerability.

How much more weight will I lose on tirzepatide versus semaglutide?

Clinical trials show tirzepatide users lose approximately 20-22% of body weight while semaglutide users lose 10-18%, a difference of 4-8 percentage points. However, individual results vary significantly based on genetics, diet, exercise, and medication adherence. Genetic testing through PlexusDx can reveal whether your metabolic profile favors dual-pathway activation.

What does PlexusDx charge for tirzepatide, and does price change with dose?

Compounded tirzepatide injection from PlexusDx starts at $249 per month and remains flat across all dose levels. Your dose may need to go up. Your price won't. The medication is available nationwide without insurance, and HSA/FSA dollars are accepted.

Is one medication safer than the other?

Both semaglutide and tirzepatide have similar safety profiles when prescribed appropriately. Serious adverse events are rare with either medication. The primary contraindication applies to both: personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. Your PlexusDx provider will screen for these conditions before starting treatment.

How does the Precision Peptide Genetic Test help me choose between these medications?

PlexusDx's genetic test identifies variants in GLP1R and GIPR genes that predict your individual response to single-pathway versus dual-pathway activation. If your genetic profile shows strong GLP1R responsiveness, semaglutide may be optimal. If GIPR variants suggest enhanced dual-pathway benefit, tirzepatide may produce superior results. The $99 test adds precision to your treatment plan after your first month.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Mounjaro For Weight Loss 2
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.